Caner Süsal
Koç University · 308 works · 7,498 citations · h-index 43
Top works
- Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation
- Antibodies against MICA Antigens and Kidney-Transplant Rejection
- Analyses of the short- and long-term graft survival after kidney transplantation in Europe between 1986 and 2015
- Identification of Highly Responsive Kidney Transplant Recipients Using Pretransplant Soluble CD30
- No Association of Kidney Graft Loss With Human Leukocyte Antigen Antibodies Detected Exclusively by Sensitive Luminex Single-Antigen Testing: A Collaborative Transplant Study Report
- Three-Year Outcomes Following 1420 ABO-Incompatible Living-Donor Kidney Transplants Performed After ABO Antibody Reduction
- SOLUBLE CD30 AS A PREDICTOR OF KIDNEY GRAFT OUTCOME1
- The collaborative transplant study registry
- Current role of human leukocyte antigen matching in kidney transplantation
- Successful Treatment of Chronic Antibody-Mediated Rejection With IVIG and Rituximab in Pediatric Renal Transplant Recipients
- Early Humoral Responses of Hemodialysis Patients after COVID-19 Vaccination with BNT162b2
- Serial Peripheral Blood Perforin and Granzyme B Gene Expression Measurements for Prediction of Acute Rejection in Kidney Graft Recipients
- Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: A Collaborative Transplant Study report
- Split liver transplantation: Current developments
- ABO-Incompatible Kidney Transplantation
- Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis
- Association of Kidney Graft Loss With De Novo Produced Donor-Specific and Non-Donor-Specific HLA Antibodies Detected by Single Antigen Testing
- Bias by censoring for competing events in survival analysis
- Post-Transplant sCD30 and Neopterin as Predictors of Chronic Allograft Nephropathy: Impact of Different Immunosuppressive Regimens
- IVIG and rituximab for treatment of chronic antibody-mediated rejection: a prospective study in paediatric renal transplantation with a 2-year follow-up